European Neuromuscular Centre Themed Workshops

The NMD4C is excited to share that the European Neuromuscular Centre (ENMC) has announced a new initiative: Themed Workshops

 

For more than 28 years, the ENMC has organised 260+ workshops, with topics originating from an international group of experts in the field of neuromuscular diseases (NMD). This is a unique concept where the scientific content of the workshop is submitted by NMD researchers and clinicians and where the logistical organisation and funding of the workshop is facilitated by the ENMC. The ENMC’s workshops are aimed to bring together researchers, clinicians and patient representatives from all over the world to encourage communication and international collaboration on specific neuromuscular conditions. The next deadline for these regular ENMC workshops is 1 September 2021!

 

For the new Themed Workshops, the ENMC will identify special themes which are prioritised by the needs of the neuromuscular patient and research community. These topics are transversal (relevant across many NMDs), multidisciplinary, unique and sustainable (with a long-lasting impact on the neuromuscular community). Organisers, who would like to pick up the theme and apply for an ENMC workshop are free to further define the rationale, background, objectives and resulting deliverables of the workshop.

 

The theme for 2021 is Post-Covid-19: Issues and opportunities for the neuromuscular field. This theme was selected to provide learning opportunities from the Covid-19 pandemic in two ways:

 

1)    to evaluate how NMD patients were assessed and their care managed during the self-isolation period, and see chances for continuing part of the online monitoring,

2)    to understand how neuromuscular signs and symptoms have developed in non-NMD patients who were infected by the Coronavirus. 

 

The call for organisers who would like to apply for an ENMC workshop on this theme is now open and will run until September 30, 2021. For more information, please visit the ENMC website!

2x3ENMC

Read next...

Muscular Dystrophy Canada is thrilled to launch an innovative initiative designed to tackle the diagnostic hurdles experienced by individuals with myotonic dystrophy.

Muscular Dystrophy Canada Launches Initiative to Improve Genetic Testing Access for Myotonic Dystrophy

Muscular Dystrophy Canada is thrilled to launch an innovative initiative designed to tackle the diagnostic hurdles experienced by individuals with myotonic dystrophy.

LEARNMD content update - February 2025

New Content Available in LEARNMD

LEARNMD is the NMD4C’s online educational platform, offering talks and sessions on a wide range of neuromuscular topics presented by leading clinical and scientific experts worldwide. We’re excited to share what’s new on LEARNMD in February 2025!

RQAS logo

Quebec Network Réseau Québécoise de l’Amyotrophie Spinale Joins NMD4C as Community of Practice Sub-Group

We are thrilled to announce that the RQAS, a network uniting rehabilitation clinicians across Quebec to advance the care of people with Spinal Muscular Atrophy has officially become a sub-group Community of Practice of the NMD4C

2024 year in review

NMD4C 2024 Year in Review

This year in review outlines a collection of achievements from the network over the past year.

2025 NM fellowship funding recipients

NMD4C and MDC Award Fellowship Funding in NMD Research and Medicine

Together the Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC) are excited to announce the 2025 recipients of our neuromuscular fellowship funding competition to award postdoctoral fellowships in neuromuscular disease (NMD) research and clinical fellowships in neuromuscular medicine and electromyography!

Meet the Basic Science Trainee Committee

NMD4C Basic Science Trainee Committee Provides Leadership Opportunity for Next Generation of Neuromuscular Researchers

The newly-formed Basic Science Trainee Committee represents the interests of trainees within the network, offering an opportunity for professional growth for future leaders in neuromuscular research.